A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.
Also called NCT03724981
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose other
- Phase
- Phase 4
- Enrolled
- 312 participants
- Sponsor
- Registry
-
NCT03724981
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT03724981. Randomized; no masking; primary purpose other. Start 2018-10-18 (actual); primary completion 2019-04-12 (actual). Results posted on 2020-04-24.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Comparing the Dulaglutide Pen and the Semaglutide Pen
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- Dulaglutide Pen
- Intervention (Drug)
- Semaglutide Pen
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct03724981- Content hash
cde0df80a73ad889e6c7094b5ab2036f1c21362030ddaf2eb8bd5eeab3928058